What is the appropriate evaluation and management of anemia in a 42‑year‑old woman?

Evaluation and Management of Anemia in a 42-Year-Old Woman

A 42-year-old woman with anemia should undergo ferritin testing using a cutoff of <45 ng/mL to diagnose iron deficiency, followed by bidirectional endoscopy if iron deficiency anemia is confirmed, though shared decision-making may favor initial iron supplementation in younger premenopausal women without alarm symptoms. 1, 2

Diagnostic Approach

Initial Laboratory Testing

• Measure serum ferritin with hemoglobin: Use ferritin <45 ng/mL as the diagnostic threshold for iron deficiency rather than the traditional <15 ng/mL cutoff, as this provides optimal sensitivity-specificity balance 1, 2
• Ferritin <15 μg/L is highly specific (99%) for iron deficiency, but the 45 μg/L cutoff is more practical in clinical practice with 92% specificity 2
• Screen for celiac disease serologically: Found in 3-5% of iron deficiency anemia cases 2
• Perform urinalysis to exclude urinary blood loss 2

Key Historical Elements to Elicit

• Menstrual history: Heavy menstrual bleeding is the most common cause in premenopausal women 3, 4
• Gastrointestinal symptoms (even subtle ones)
• Dietary intake and absorption issues
• Family history of GI malignancy
• Recent pregnancy or lactation

Management Algorithm

For Confirmed Iron Deficiency Anemia

The decision point hinges on age, symptoms, and patient values:

Option 1: Bidirectional Endoscopy (Conditional Recommendation)

• AGA suggests bidirectional endoscopy over iron replacement alone in asymptomatic premenopausal women with IDA 1
• British guidelines recommend gastroscopy and colonoscopy as first-line in men and postmenopausal women (strong recommendation) 2
• However, at age 42, the risk of GI malignancy is extremely low, and this must be weighed against endoscopy risks 1

Option 2: Initial Iron Supplementation (Reasonable Alternative)

Patients who place high value on avoiding endoscopy risks—particularly younger women with plausible menstrual causes—may reasonably choose initial iron replacement with monitoring 1

This approach is explicitly endorsed in the AGA guidelines for younger premenopausal women without alarm symptoms.

Iron Replacement Strategy

• Oral ferrous sulfate in slow-release formulation is first-line: well-tolerated with good adherence 4
• Intravenous iron reserved for:
  • Intolerance to oral iron
  • Malabsorption
  • Need for rapid repletion
  • Failure of oral therapy 5

Follow-Up Protocol

• Recheck hemoglobin and ferritin after 4-6 weeks of iron therapy 3
• If no response to adequate iron supplementation, proceed to endoscopy regardless of initial choice 1
• Continue iron until ferritin >30 μg/L and hemoglobin normalizes 2

Additional Testing After Negative Endoscopy

If bidirectional endoscopy is performed and negative:

1. Test for H. pylori non-invasively and treat if positive (conditional recommendation): Associated with decreased iron absorption and peptic ulcer disease 1
2. Consider small bowel evaluation with video capsule endoscopy only if iron supplementation fails 1
3. Routine gastric biopsies for atrophic gastritis are NOT recommended 1

Critical Pitfalls to Avoid

• Don't use ferritin <15 ng/mL as the sole cutoff: This misses many cases of iron deficiency, especially with concurrent inflammation 1, 2
• Don't skip celiac screening: It's found in 3-5% of IDA cases and changes management 2
• Don't automatically endoscope all premenopausal women: The cancer risk at age 42 is extremely low, and shared decision-making is appropriate 1
• Don't forget to document menstrual history: Only 72% of clinicians document this despite it being the most common cause 3
• Don't fail to follow up: Only 15% of patients receive appropriate hemoglobin follow-up testing in practice 3

The Nuanced Reality

The guidelines present a tension: AGA (2020) suggests bidirectional endoscopy even in premenopausal women 1, while acknowledging that younger women with plausible menstrual causes may reasonably defer endoscopy. The British guidelines (2021) are more conservative, noting that GI investigation "generally is not warranted in premenopausal women" with NAID absent other risk factors 2.

For a 42-year-old woman, the practical approach is shared decision-making: Discuss that GI malignancy risk is very low at her age, menstrual blood loss is the likely cause, but endoscopy provides definitive evaluation. If she has heavy menstrual bleeding, no GI symptoms, and no family history of GI cancer, initial iron supplementation with close monitoring is entirely reasonable and explicitly supported by guidelines.